These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30611516)

  • 41. Synergistic interactions of apigenin, naringin, quercetin and emodin on inhibition of 3T3-L1 preadipocyte differentiation and pancreas lipase activity.
    Guo X; Liu J; Cai S; Wang O; Ji B
    Obes Res Clin Pract; 2016; 10(3):327-39. PubMed ID: 26314502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasorelaxant activity of 7-β-O-glycosides biosynthesized from flavonoids.
    Penso J; Cordeiro KC; da Cunha CR; da Silva Castro PF; Martins DR; Lião LM; Rocha ML; de Oliveira V
    Eur J Pharmacol; 2014 Jun; 733():75-80. PubMed ID: 24704375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of binding efficacies of DNA to flavonoids and their induced cellular damage.
    Das A; Majumder D; Saha C
    J Photochem Photobiol B; 2017 May; 170():256-262. PubMed ID: 28456117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flavonoid-drug interactions: effects of flavonoids on ABC transporters.
    Morris ME; Zhang S
    Life Sci; 2006 Mar; 78(18):2116-30. PubMed ID: 16455109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
    An G; Gallegos J; Morris ME
    Drug Metab Dispos; 2011 Mar; 39(3):426-32. PubMed ID: 21139040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
    Miniscalco A; Lundahl J; Regårdh CG; Edgar B; Eriksson UG
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1195-9. PubMed ID: 1602384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery.
    Calcagno AM; Ludwig JA; Fostel JM; Gottesman MM; Ambudkar SV
    Mol Pharm; 2006; 3(1):87-93. PubMed ID: 16686373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and characterization of a SIRT6 open tubular column: predicting deacetylation activity using frontal chromatography.
    Singh N; Ravichandran S; Norton DD; Fugmann SD; Moaddel R
    Anal Biochem; 2013 May; 436(2):78-83. PubMed ID: 23376017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary flavonoids: bioavailability, metabolic effects, and safety.
    Ross JA; Kasum CM
    Annu Rev Nutr; 2002; 22():19-34. PubMed ID: 12055336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability.
    Wen X; Walle T
    Drug Metab Dispos; 2006 Oct; 34(10):1786-92. PubMed ID: 16868069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model.
    Hu M; Chen J; Lin H
    J Pharmacol Exp Ther; 2003 Oct; 307(1):314-21. PubMed ID: 12893842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer.
    Boyer J; Brown D; Liu RH
    Nutr J; 2005 Jan; 4():1. PubMed ID: 15644141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of friedelin on the intestinal permeability and bioavailability of apigenin.
    Lee JA; Ha SK; Kim YC; Choi I
    Pharmacol Rep; 2017 Oct; 69(5):1044-1048. PubMed ID: 28939344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.
    Li Y; Paxton JW
    Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):267-85. PubMed ID: 23289831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structurally Different Flavonoid Subclasses Attenuate High-Fat and High-Fructose Diet Induced Metabolic Syndrome in Rats.
    Zhang J; Zhao L; Cheng Q; Ji B; Yang M; Sanidad KZ; Wang C; Zhou F
    J Agric Food Chem; 2018 Nov; 66(46):12412-12420. PubMed ID: 30360615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function.
    Terao J
    Biochem Pharmacol; 2017 Sep; 139():15-23. PubMed ID: 28377278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow Cytometric Method for the Detection of Flavonoids in Cell Lines.
    Grootaert C; Gonzales GB; Vissenaekens H; Van de Wiele T; Raes K; Smagghe G; Van Camp J
    J Biomol Screen; 2016 Sep; 21(8):858-65. PubMed ID: 27280551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of edible oils on quercetin, kaempferol and galangin transport and conjugation in the intestinal Caco-2/HT29-MTX co-culture model.
    Jailani F; Williamson G
    Food Funct; 2014 Apr; 5(4):653-62. PubMed ID: 24525490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.